UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF

THE SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): ~~May~~October 1519, 2020

GSRX INDUSTRIES INC.

(Exact name of registrant as specified in its charter)

Nevada

333-141929

14-1982491

(State or other jurisdiction

of incorporation)

(Commission

File Number)

(I.R.S. Employer

Identification Number)

Building No. 3, P.E. 606, int. Jose Efron Ave.

Dorado, Puerto Rico 00646

(Address of principal executive offices), (and zip code)

(214) 808-8649

(Registrant’s telephone number, including area code)

N/A

(Former ~~name~~Name or ~~former~~Former ~~address~~Address, if ~~changed~~Changed ~~since~~Since ~~last~~Last ~~report~~Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

[ ]	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

[ ]	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

[ ]	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

[ ]	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
N/A		N/A		N/A

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company [ ]

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [ ]

Item 81.01 ~~Other~~Entry ~~Events~~into a Material Definitive Agreement.

~~GSRX~~On October 19, 2020, GSRX Industries Inc. (the “Company”) ~~will~~announced beit ~~relying~~has onsold the Securities and Exchange Commission’s Order under Section 36 of the Securities Exchange Act of 1934 Modifying Exemptions From Reporting and Proxy Delivery Requirements for Public Companies dated March 25, 2020 (Release No. 34-88465) to delay the filing of its ~~Quarterly~~95% ~~Report~~interest onin ~~Form 10-Q for~~ the ~~quarter~~Green ~~ended~~Room ~~March~~Palm 31Springs, ~~2020~~LLC (the “~~Report~~Dispensary”) ~~due to circumstances related to coronavirus, or COVID-19~~. The ~~Company’s~~Dispensary ~~principal~~was ~~operating and~~purchased ~~manufacturing facilities are located in the United States and most of its employees are residents of the United States. The United States has been severely impacted~~ by ~~COVID-19~~Seneca ~~outbreak,~~Capital ~~resulting in authorities implementing numerous measures to try to contain the virus~~Partners, ~~such~~LP ~~as travel bans and restrictions, quarantines, shelter in place orders, and shutdowns. In particular, our office staff members responsible~~ for ~~preparing~~a ~~and~~total ~~providing supporting materials and information in preparation~~ of ~~the Report are located in the United States~~USD$400, ~~and COVID-19 and the resulting government measures have caused disruptions in the Company’s normal interactions with among such persons~~000. ~~Because of the United States government-mandated quarantine, the Company’s~~ ~~staff~~The ~~are now working remotely and creating unforeseen inefficiencies, leading to a significant delay in the~~ Company’s ~~ability to~~will ~~prepare~~also ~~and~~receive ~~review~~3% ~~the~~of ~~Company’s~~gross ~~financial~~revenue ~~statements~~ for ~~the~~60 ~~quarter~~months ~~ended~~from ~~March 31, 2020 necessary for filing of~~ the ~~Report.~~ ~~The~~date ~~Company expects to file~~ the ~~Report~~Dispensary nobegins ~~later than June 29, 2020 (which is 45 days from the Report’s original filing deadline of May 15, 2020)~~operations.

InItem ~~light~~7.01. ofRegulation ~~the~~FD ~~current COVID-19 pandemic, the Company will be including the following Risk Factor in its Report, as may be updated to reflect subsequent events impacting the Company:~~Disclosure.

~~The~~On ~~recent~~October ~~coronavirus~~19, ~~outbreak~~2020, ~~may~~the ~~adversely~~Corporation ~~affect~~issued ~~our~~a ~~business~~press release announcing the sale of its interest in the Dispensary. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated into this Item 7.01 by reference.

InItem December 2019, a strain of coronavirus was reported to have surfaced in Wuhan, China, and has reached multiple other countries, resulting in government-imposed quarantines, travel restrictions and other public health safety measures in China, the U9.~~S.,~~01 ~~Italy, Israel~~Financial ~~and~~Statements ~~other affected countries. The continued outbreak~~ and ~~spreading of the coronavirus has and may continue to adversely impact our business, as our operations are based in the United States which has been severely affected by the outbreak~~Exhibits. The various precautionary measures taken by many governmental authorities around the world in order to limit the spread of the coronavirus has had and may continue to have an adverse effect on the global markets and global economy, including on the availability and pricing of employees, resources, materials, manufacturing and delivery efforts and other aspects of the global economy. The financial downturn has compelled us to furlough or reduce working hours for much of our operating staff, as well as third-party contractors, and our clients may encounter cash-flow issues that will delay their payments to us. We also rely on third-party professionals to provide services such as the preparation of our financial statements and to conduct audits, and many of these parties have been affected by government-imposed precautionary measures, thereby delaying our receipt of these services. Therefore, the coronavirus has and could continue to disrupt production and cause delays in the supply and delivery of our products, may continue to affect our operation and disrupt the marketplace in which we operate and may have a material adverse effect on our operations. The extent to which the coronavirus impacts our results will depend on future developments, which are highly uncertain and cannot be predicted, including new information which may emerge concerning the severity of the coronavirus and the actions to contain the coronavirus or treat its impact, among others. The development of the coronavirus outbreak could materially disrupt our business and operations, hamper our ability to raise additional funds or sell our securities, continue to slow down the overall economy, curtail consumer spending, interrupt our sources of supply, and make it hard to adequately staff our operations.

Exhibit No.		Description

10.1		Purchase Agreement between Seneca Capital Partners, LP and GSRX Industries Inc.
10.2		Revenue Sharing Agreement between Green Room Palm Springs, LLC and GSRX Industries Inc.
10.3		Security and Pledge Agreement between Green Room Palm Springs, LLC and GSRX Industries Inc.
99.1		Press Release dated October 19, 2020

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	GSRX INDUSTRIES INC.
Dated: May 15, 2020	By:	/s/ Troy Nihart
Dated: October 22, 2020	By:	/s/ Troy Nihart
	Name:	Troy Nihart
	Title:	Interim President &and CEO

Filing Compare · GSRX INDUSTRIES INC.